Volitionrx Ltd
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleos… Read more
Volitionrx Ltd (VNRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.097x
Based on the latest financial reports, Volitionrx Ltd (VNRX) has a cash flow conversion efficiency ratio of 0.097x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.47 Million) by net assets ($-35.95 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Volitionrx Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Volitionrx Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Volitionrx Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Volitionrx Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Acanthe Développement
PA:ACAN
|
-0.049x |
|
ParaZero Technologies Ltd. Ordinary Shares
NASDAQ:PRZO
|
-0.242x |
|
SEAL Incorporated Bhd
KLSE:4286
|
0.022x |
|
Tah Kong Chemical Industrial
TWO:4706
|
0.003x |
|
Thai Rung Union Car Public Company Limited
BK:TRU
|
0.013x |
|
Applus Servicios Tecnologicos
MC:APPS
|
0.082x |
|
SYSTEM1 GROUP LS-01
F:BBA
|
N/A |
|
Eildon Capital Group
AU:EDC
|
0.319x |
Annual Cash Flow Conversion Efficiency for Volitionrx Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Volitionrx Ltd from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-26.11 Million | $-25.89 Million | 0.992x | -52.16% |
| 2023-12-31 | $-8.71 Million | $-18.06 Million | 2.073x | -57.56% |
| 2022-12-31 | $-3.13 Million | $-15.28 Million | 4.886x | +515.21% |
| 2021-12-31 | $17.72 Million | $-20.85 Million | -1.177x | -16.45% |
| 2020-12-31 | $16.29 Million | $-16.46 Million | -1.010x | -12.62% |
| 2019-12-31 | $14.20 Million | $-12.74 Million | -0.897x | +26.07% |
| 2018-12-31 | $12.14 Million | $-14.73 Million | -1.214x | +0.89% |
| 2017-12-31 | $9.96 Million | $-12.19 Million | -1.224x | -186.32% |
| 2016-12-31 | $21.18 Million | $-9.06 Million | -0.428x | +70.51% |
| 2015-12-31 | $6.04 Million | $-8.77 Million | -1.450x | +87.10% |
| 2014-12-31 | $368.18K | $-4.14 Million | -11.247x | -148.21% |
| 2013-12-31 | $680.67K | $-3.08 Million | -4.531x | -63.23% |
| 2012-12-31 | $833.79K | $-2.31 Million | -2.776x | -79.29% |
| 2011-12-31 | $1.09 Million | $-1.69 Million | -1.548x | -3905.47% |
| 2010-12-31 | $-114.29K | $-4.65K | 0.041x | -23.90% |
| 2009-12-31 | $-107.54K | $-5.75K | 0.053x | +112.84% |
| 2008-12-31 | $-95.92K | $39.95K | -0.416x | -288.41% |
| 2007-12-31 | $-78.32K | $-17.31K | 0.221x | -75.14% |
| 2006-12-31 | $-56.23K | $-50.00K | 0.889x | +185417.27% |
| 2005-12-31 | $-72.94K | $35.00 | 0.000x | -148.77% |
| 2004-12-31 | $-64.03K | $-63.00 | 0.001x | -- |